On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

CAVIN1

caveolae associated protein 1

The CAVIN1 gene provides instructions for producing the cavin-1 protein, which is critical for the formation and stability of caveolae, small invaginations on cell membranes involved in various cellular processes. CAVIN1 encodes the cavin-1 protein, predominantly found in bone-building cells, muscle cells, and fat cells.

Chromosome 17q21.2 HGNC:9688 Tier C
CAVIN1 17q21.2 p arm q arm 17

CAVIN1 is located on the long (q) arm of chromosome 17, at band 17q21.2. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 17 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The CAVIN1 gene directs the production of the cavin-1 protein, a crucial component found in cells and tissues throughout the body. It is particularly prevalent in osteoblasts, which are cells responsible for bone formation, as well as in muscle cells and adipocytes, which store fat. Cavin-1 is vital for both the assembly and the structural integrity of caveolae, which are small, flask-shaped pockets on the surface of cell membranes.

Beyond its fundamental role in caveolae, the cavin-1 protein is also implicated in other cellular processes. These include repairing damage to the cell membrane, regulating cell growth and movement, and influencing cellular senescence, which is the process of cell ageing. The specific roles of cavin-1 can differ based on the cell type and its subcellular location.

What the gene does

The cavin-1 protein, produced from the CAVIN1 gene, is essential for creating and maintaining caveolae, which are invaginations of the plasma membrane. These structures are involved in cellular uptake of molecules (endocytosis), lipid regulation, and the transmission of signals within cells. Cavin-1 helps to stabilise caveolae, allowing them to effectively perform their diverse functions, especially in adipocytes where they are important for the transport, processing, and storage of fats.

Inside cells, cavin-1 is found both in the cytoplasm and within the nucleus, suggesting broader functions beyond its role in caveolae formation. Research indicates that it also participates in cellular proliferation, cell movement, and the process of senescence. Furthermore, it contributes to mechanisms for repairing cell membranes after damage. The wide range of functions attributed to cavin-1 highlights its significance in overall cellular health and metabolic regulation.

Video: Genetics 101

Chromosome location

The CAVIN1 gene is situated on chromosome 17 at position 17q21.2. This gene contains the instructions for synthesising the cavin-1 protein, which consists of 390 amino acids. Understanding its precise genomic location helps in studying its genetic context and potential interactions with nearby genes.

Protein structure

The cavin-1 protein contains several distinct regions that enable its molecular interactions and functions. A segment spanning amino acids 1-98 is necessary for the protein to form homotrimers and to interact with other cavin proteins, CAVIN2 and CAVIN3. The N-terminal part, from amino acids 1-40, is a disordered region. A nuclear export signal is located between amino acids 52-62, while a leucine-zipper 1 motif is found from amino acids 53-75. Further along the protein, a nuclear localisation signal exists from amino acids 136-152, followed by a second leucine-zipper (amino acids 166-186). Another disordered region is present between amino acids 172-201. A significant coiled-coil domain extends from amino acids 199-282, which facilitates protein-protein interactions. A second nuclear localisation signal is identified at amino acids 233-249, and a third leucine-zipper (amino acids 257-297) is also present. The C-terminal end includes another disordered region from amino acids 344-366.

Domain map · 390 amino acids
Required for homotrimerization and for interaction with CAVIN2 and CAVIN3 (1-98)Nuclear export signal (52-62)Leucine-zipper 1 (53-75)Nuclear localization signal (136-152)Leucine-zipper 2 (166-186)Coiled coil (199-282)Nuclear localization signal (233-249)Leucine-zipper 3 (257-297)Required for homotrime1-98Coiled coil199-282Leucine-zipper 3257-2971~195390
Region - functional region
Region - functional region
🧬 Explore 3D structure on AlphaFold
UniProt:Q6NZI2Length:390 aaStructure:AlphaFold

Key variants

Variants in the CAVIN1 gene can alter the production or function of the cavin-1 protein. Such genetic changes may disrupt the normal formation or stability of caveolae, impacting crucial cellular processes. The clinical implications of these variants can range depending on their specific nature and location within the gene.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for CAVIN1.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.518_521del
Deletion
p.Lys173fs Pathogenic/Likely pathogenic ★★☆☆ Congenital generalized lipodystrophy type 4
c.141_148del
Deletion
p.Asp47fs Pathogenic ★☆☆☆ Congenital generalized lipodystrophy
c.462del
Deletion
p.Met154fs Pathogenic ★☆☆☆ not provided
c.696dup
Duplication
p.Lys233fs Pathogenic ★☆☆☆ Congenital generalized lipodystrophy type 4
c.135del
Deletion
p.Lys45fs Pathogenic - Congenital generalized lipodystrophy type 4
c.160del
Deletion
p.Val54fs Pathogenic - Congenital generalized lipodystrophy type 4
c.259C>T
single nucleotide variant
p.Gln87Ter Pathogenic - Congenital generalized lipodystrophy type 4
c.362dup
Duplication
p.Lys122fs Pathogenic - Congenital generalized lipodystrophy type 4
c.471+1G>T
single nucleotide variant
- Pathogenic - Congenital generalized lipodystrophy type 4
c.478_481dup
Duplication
p.Lys161fs Pathogenic - Congenital generalized lipodystrophy type 4

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the CAVIN1 gene are associated with inherited conditions, particularly those affecting fat distribution and metabolic function. One such condition is congenital generalised lipodystrophy type 4, a rare disorder characterised by a near-total absence of adipose tissue. This lack of fat tissue can lead to several health complications. More than 10 pathogenic variants in the CAVIN1 gene have been identified in individuals with this condition; however, information regarding the full characteristics of the condition is incomplete in the provided data.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

In the UK, the CAVIN1 gene is recognised within the NHS Genomic Medicine Service due to its association with specific inherited conditions. It is included on national panels for Congenital muscular dystrophy (R79), Insulin resistance (including lipodystrophy), and Severe insulin resistance and lipodystrophy syndromes (R158). This inclusion indicates that genetic testing for CAVIN1 variants may be considered for individuals presenting with symptoms related to these conditions.

Frequently asked questions

What is the primary function of the CAVIN1 gene?

The CAVIN1 gene provides instructions for the cavin-1 protein, which is essential for the formation and stabilisation of caveolae, small invaginations on cell membranes. These structures play roles in molecular transport, cellular signalling, and fat metabolism.

Which conditions are associated with CAVIN1 variants?

Variants in the CAVIN1 gene are primarily associated with congenital generalised lipodystrophy type 4, a rare condition characterised by a significant lack of body fat and associated metabolic issues.

Where is the CAVIN1 gene located?

The CAVIN1 gene is located on chromosome 17, specifically at position 17q21.2.

References

  1. Low JY, Nicholson HD. Emerging role of polymerase-1 and transcript release factor (PTRF/ Cavin-1) in health and disease. Cell and tissue research. 2014. PMID: 25107607
  2. Rajab A, Straub V, McCann LJ. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS genetics. 2010. PMID: 20300641
  3. Shastry S, Delgado MR, Dirik E. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. American journal of medical genetics. Part A. 2010. PMID: 20684003
  4. Hayashi YK, Matsuda C, Ogawa M. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. The Journal of clinical investigation. 2009. PMID: 19726876
  5. Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. The Journal of biological chemistry. 2008. PMID: 18056712
  6. Hill MM, Bastiani M, Luetterforst R. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008. PMID: 18191225
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .